Skip to main content
. 2014 Aug 21;8(5):2243–2248. doi: 10.3892/ol.2014.2472

Table I.

Patient characteristics in the gemcitabine/docetaxel and pemetrexed/cisplatin treatment groups.

Clinicopathological parameter Gemcitabine/docetaxel Pemetrexed/cisplatin P-value
Gender >0.05
 Male 15 14
 Female 6 4
Age (years) >0.05
 <18 11 11
 ≥18 10 7
Location >0.05
 Limbs 18 16
 Nonextremities 3 2
Histotype >0.05
 Conventional 18 17
 Others 3 1
Surgical >0.05
 Amputation 7 6
 Limb salvage 14 12
Metastasis at diagnosis >0.05
 Yes 11 8
 No 10 10